Posted on 1/6/21
Adeptrix Closes Series A
Adeptrix Corp, the developer of advanced bioanalytical tools based on its proprietary BAMS™ (Bead Assisted Mass Spectrometry)
Posted on 1/6/21
CNC Software Appoints Paco Agrafojo as Marketing Director
CNC Software, Inc., the developers of Mastercam, announced that Paco Agrafojo has been hired in the role of Marketing Director. Mastercam is the world's most widely . . .
Posted on 1/6/21
Alkermes Appoint Blair C. Jackson Appointed COO and Iain M. Brown Named CFO
Alkermes plc (Nasdaq: ALKS), a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology, today announced a series of changes . . .
Posted on 1/6/21
Raytheon Technologies Appoints Marie R. Sylla-Dixon as Chief Diversity Officer
Raytheon Technologies (NYSE: RTX) today announced that Marie R. Sylla-Dixon has joined the company effective Jan. 4, 2021 as chief diversity officer (CDO). Sylla-Dixon will report . . .
Posted on 1/6/21
Navisite Acquires Velocity Technology Solutions
Navisite today announced that it has acquired Velocity Technology Solutions, Inc., a global cloud managed service provider (MSP). With this acquisition, Navisite enhances its position as . . .
Posted on 1/6/21
CVS Health Appoints Michelle Peluso As Chief Customer Officer
CVS Health (NYSE: CVS) today announced that Michelle Peluso will join the company as Chief Customer Officer effective January 25. In this newly created executive leadership . . .
Posted on 1/6/21
Boston Digital Promotes Peter Prodromou to CEO
Boston Digital today announced changes at the executive level with founder Chuck Murphy stepping into the role of Chairman of the Board, and naming current President, . . .
Posted on 1/6/21
Beth R. Myers Joins Burns & Levinson as a Partner
Burns & Levinson announced today that well-known plaintiff employment litigator Beth R. Myers has joined the firm as a partner in its Business Litigation & Dispute . . .
Posted on 1/6/21
Bill Reidy Joins LotLinx as Chief Revenue Officer
LotLinx, the automotive industry's leading Vehicle Marketing System, announced today that veteran sales executive Bill Reidy has joined the company's senior leadership team as Chief Revenue . . .
Posted on 1/6/21
HCR Expands Team and Announces Promotions
STAMFORD, Conn.--(BUSINESS WIRE)--HealthCare Royalty Management, a global healthcare royalty acquisition firm, today announced several firm developments:Expansion of West Coast Presence:HCR has appointed Matthew H. Bullard as . . .
Posted on 1/6/21
Newmark Completes Sale of 601 Congress in Boston, Massachusetts
Newmark announces the sale of 601 Congress, a laboratory conversion opportunity located in the Seaport District of Boston, Massachusetts. Newmark Co-Head of U.S. Capital Markets Robert . . .
Posted on 1/6/21
Brainwave Science Announces its Scientific Advisory Board
Brainwave Science today announced its Scientific Advisory Board, which includes such well known industry figures as Dr. Peter Rosenfeld, Dr. Laxmidhar Bedera
Posted on 1/6/21
Ariel Property Advisors Exclusively Lists 26K-SF Mixed-Use Property in West Harlem
Ariel Property Advisors has exclusively listed 149 West 105th Street, a 7-story, 25,816-square-foot, mixed-use elevator building with 49 feet of frontage between Amsterdam and Columbus Avenues . . .
Posted on 1/6/21
Entrada Therapeutics Appoints Dr. Peter Kim to Board
Entrada Therapeutics, a privately-held biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular biologics, today announced the appointment of Peter S. Kim, Ph.D
Posted on 1/6/21
Jnana Therapeutics Appoints Dr. Annie Chen to Board of Directors and Dr. Katalin Susztak to Scientific Advisory Board
BOSTON--(BUSINESS WIRE)--Jnana Therapeutics, a biotechnology company targeting the solute carrier (SLC) family of metabolite transporters to treat underserved diseases, today announced the appointment of two experienced . . .
Posted on 1/6/21
Dr. Joachim Hasenmaier Joins Invetx Board of Directors
Invetx, a pioneer in protein-based therapeutics for animal health, announced today that Dr. Joachim Hasenmaier has joined the company’s board of directors.
Posted on 1/6/21
Gutenberg Technology Appoints Dr. Adam Black to Advisory Board
BOSTON--(BUSINESS WIRE)--Gutenberg Technology (GT), provider of the premier end-to-end content management platform, today announced the appointment of Dr. Adam Black to its advisory board, effective immediately. . . .
Posted on 1/6/21
THL Completes Sale of 50% Stake in CSafe Global to Frazier Healthcare Partners
BOSTON--(BUSINESS WIRE)--CSafe Global, a leading provider of cold chain shipping solutions to global pharmaceutical and life sciences companies, and portfolio Company of Thomas H. Lee Partners, . . .
Posted on 1/6/21
BioMed Realty Acquires Flagship Property in Boston’s Seaport District
BOSTON--(BUSINESS WIRE)--BioMed Realty, a leading provider of real estate solutions to the life science and technology industries, today announced the acquisition of 601 Congress Street in . . .
Posted on 1/6/21
Alegeus Appoints Leif O’Leary as Chief Executive Officer
Alegeus, the market leader in consumer-directed healthcare (CDH) solutions, has welcomed three new members to its executive leadership team over the past several months: Leif O’Leary
Posted on 1/6/21
Verastem Oncology Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the appointment of . . .
Posted on 1/6/21
Berkshire Hathaway Specialty Insurance Appoints Brady Head as SVP
BOSTON--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has named Brady Head as Senior Vice President, Product Line Officer for D&O Liability Insurance in . . .
Posted on 1/6/21
Starburst Secures $100M Series C
Starburst, the analytics anywhere company, today announced $100 million in Series C funding, bringing the three-year-old company’s total financing to $164 million and valuation to $1.2 . . .
Posted on 1/6/21
Aileron Therapeutics Announces $35.9 Million Registered Direct Offering
WATERTOWN, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (Nasdaq: ALRN), today announced that it has entered into definitive agreements with fundamental healthcare investors . . .
Posted on 1/6/21
Myeloid Therapeutics Raises Over $50M in Financing
Myeloid Therapeutics, Inc., a Cambridge, Mass.-based company harnessing and reprogramming myeloid cells for treating cancers, launched with over $50m in financing.
Boston
